Zentalis Pharmaceuticals, Inc.: Wells Fargo Securities Raises Its Buy Recommendation








Marketzone with MT Newswires 2022

All the news about ZENTALIS PHARMACEUTICALS, INC.

Analyst Recommendations for ZENTALIS PHARMACEUTICALS, INC.

2022 turnover –
–
–
2022 net result -235M
–
-215M
trso. net 2022 348M
–
319M
PER 2022-9.76x
2022 return–
Capitalization 2,244M
2,244M
2,053M
VE / CA 2022–
VE / CA 2023352x
Number of employees177
Floating91.1%

Chart ZENTALIS PHARMACEUTICALS, INC.


Tough :

Period:




Zentalis Pharmaceuticals, Inc.: Zentalis Pharmaceuticals, Inc. Technical Analysis Chart | Market area

Trends Technical Analysis ZENTALIS PHARMACEUTICALS, INC.

Short termMiddle termLong term
TrendsbullishbearishBearish

Evolution of the Income Statement

Sale

Purchase

Average recommendationTO BUY
Number of Analysts10
Last Closing Price$49.24
Average price target$92.80
Deviation / Average Target88.5%

Officers and Directors




Source link -88